PHRI contribution to today’s tuberculosis diagnostics

TB – IGRA

PHRI developed M. tuberculosis-specific reagents utilized in Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection.


GeneXpert

PHRI developed the molecular beacon technology that is used in the Cepheid Xpert MTB/RIF assay to diagnose active tuberculosis, including some forms of antibiotic-resistant tuberculosis.


FujiLAM

PHRI developed reagents utilized in the most recent version of the assay detecting M. tuberculosis LAM (lipoarabinomannan) in the urine of people having active tuberculosis.